NCT05828082 2026-04-14
Testing the Effect of M1774 on Hard-to-Treat Refractory SPOP-mutant Prostate Cancer
National Cancer Institute (NCI)
Phase 2 Active not recruiting
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Children's Oncology Group
Baylor College of Medicine
Children's Oncology Group
City of Hope Medical Center
UNICANCER
Thomas Jefferson University
M.D. Anderson Cancer Center
National Cancer Institute (NCI)
National Cancer Institute (NCI)